- News Home
17 April 2014 12:48 pm ,
Vol. 344 ,
Officials last week revealed that the U.S. contribution to ITER could cost $3.9 billion by 2034—roughly four times the...
An experimental hepatitis B drug that looked safe in animal trials tragically killed five of 15 patients in 1993. Now,...
Using the two high-quality genomes that exist for Neandertals and Denisovans, researchers find clues to gene activity...
A new report from the Intergovernmental Panel on Climate Change (IPCC) concludes that humanity has done little to slow...
Astronomers have discovered an Earth-sized planet in the habitable zone of a red dwarf—a star cooler than the sun—500...
Three years ago, Jennifer Francis of Rutgers University proposed that a warming Arctic was altering the behavior of the...
- 17 April 2014 12:48 pm , Vol. 344 , #6181
- About Us
Last Hurrah From National Academies Stem Cell Committee
26 May 2010 4:15 pm
Even though the National Institutes of Health (NIH) issued stem cell guidelines last year, there's still a need for guidelines for research that remains off-limits for U.S. government-funded labs. That's one message from a brief final report released today by the National Academies' National Research Council and Institute of Medicine committee on human embryonic stem (hES) cells.
In its third update to a 2005 report, the committee says that NIH's guidance should prevail over the Academies' whenever there's overlap. But guidelines such as the Academies' are still needed for research that can't be done with federal grants, says the six-page report (not counting appendices). That includes the derivation of new lines, work involving animal-human cell chimeras, and studies with lines made from embryos that were created for research purposes.
The committee decided to disband because any big controversies in the future will likely center on the uses of stem cells rather than their derivation. But the National Academies may want to hold forums with stakeholders on stem cell topics, the report suggests.